Compositions and methods related to activatable therapeutic agents
Described herein are methods for assessing likelihood of response of subjects to activatable therapeutic agents and compositions, kits, and methods of preparing and using activatable therapeutic agents. Also described herein are methods for assessing likelihood of response of subjects to activatable...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
16.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Described herein are methods for assessing likelihood of response of subjects to activatable therapeutic agents and compositions, kits, and methods of preparing and using activatable therapeutic agents. Also described herein are methods for assessing likelihood of response of subjects to activatable therapeutic agents. In some cases, the activatable therapeutic agents of the compositions, kits, and methods disclosed herein can comprise a mammalian protein-derived sequence. |
---|---|
Bibliography: | Application Number: AU20210312245 |